Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis.

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This will be a multicenter, double-blind clinical trial to evaluate the safety and efficacy of two doses of prolonged release pirfenidone, compared against placebo plus conventional therapy in patients with compensated liver cirrhosis. The study will be conducted in compliance with International Standard good clinical practices (GCPs) and the Declaration of Helsinki. The protocol is approved by a local Institutional Review Board and registered in clinical trials.gov.
Epistemonikos ID: e15db48ef47440d58d4e524dcef59af285ebb61f
First added on: May 15, 2024